1. 1) “In Vitro In Vivo Evaluation of Dosage Forms,” United States of Pharmacopeia XXIII chapter, United States Pharmacopeial Convention, Incorporated, Rockville, Maryland, 1988, pp. 1927—1929.
2. 2) Gibaldi M., Perrier D., “Pharmacokinetics,” 2nd ed., Marcel Dekker, New York, 1982.
3. 3) USP Subcommittee on Biopharmaceutics, In Vitro In Vivo correlation for extended release oral dosage forms. Phar. Forum, July–Aug., 1988, pp. 4160—4161.
4. Report of the Workshop on In Vitro and In Vivo Testing and Correlation for Oral Controlled/Modified-Release Dosage Forms
5. 5) “Guidance for the industry; Extended-release solid oral dosage forms: Development, evaluation and application of in vitro/in vivo correlations,” U.S. Department of Health, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), September, 1997.